ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.98
0.86%
US Tech 100
20,877.20
1.72%
S&P 500
5,996.66
1.00%
US Dollar vs CAD
1.44815
0.00%
Bitcoin
104,948.62
0.51%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Hikma Pharmaceuticals Plc (HIK)

  7. Hikma Pharmaceuticals Plc (HIK) News

HIK

Hikma Pharmaceuticals (HIK)

Hikma Pharmaceuticals Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:HIK
DateTimeSourceHeadlineSymbolCompany
01/14/20256:41AMPR Newswire (US)Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mgLSE:HIKHikma Pharmaceuticals Plc
12/23/20243:46AMRNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
11/07/20249:30AMRNS Regulatory NewsHikma Pharmaceuticals Plc Outcome of Audit Tender ProcessLSE:HIKHikma Pharmaceuticals Plc
11/07/20244:59AMAlliance NewsAlliance NewsHikma Pharmaceuticals reiterates full-year guidance amid strong growthLSE:HIKHikma Pharmaceuticals Plc
11/07/20244:59AMAlliance NewsAlliance NewsHikma Pharmaceuticals reiterates full-year guidance amid strong growthLSE:HIKHikma Pharmaceuticals Plc
11/07/20241:00AMRNS Regulatory NewsHikma Pharmaceuticals Plc Trading StatementLSE:HIKHikma Pharmaceuticals Plc
10/24/20241:00AMRNS Regulatory NewsHikma Pharmaceuticals Plc 2024 Annual General Meeting Update StatementLSE:HIKHikma Pharmaceuticals Plc
10/01/20243:45AMRNS Regulatory NewsHikma Pharmaceuticals Plc Block listing Interim ReviewLSE:HIKHikma Pharmaceuticals Plc
09/24/20244:09AMRNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
09/10/20243:09AMAlliance NewsAlliance NewsHikma Pharmaceuticals completes acquisition of Xellia's FDF businessLSE:HIKHikma Pharmaceuticals Plc
09/10/20243:09AMAlliance NewsAlliance NewsHikma Pharmaceuticals completes acquisition of Xellia's FDF businessLSE:HIKHikma Pharmaceuticals Plc
09/10/20241:00AMRNS Regulatory NewsHikma Pharmaceuticals Plc Hikma completes Xellia acquisitionLSE:HIKHikma Pharmaceuticals Plc
09/03/20246:46AMAlliance NewsAlliance NewsIN THE KNOW: Berenberg sees "standout" year at Hikma's Injectibles armLSE:HIKHikma Pharmaceuticals Plc
09/03/20246:46AMAlliance NewsAlliance NewsIN THE KNOW: Berenberg sees "standout" year at Hikma's Injectibles armLSE:HIKHikma Pharmaceuticals Plc
08/20/202411:15AMPR Newswire (US)Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention DayLSE:HIKHikma Pharmaceuticals Plc
08/15/20242:18PMPR Newswire (US)KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 monthsLSE:HIKHikma Pharmaceuticals Plc
08/13/20244:16AMAlliance NewsAlliance NewsIN BRIEF: Hikma executive Bassam Kanaan sells 45,000 sharesLSE:HIKHikma Pharmaceuticals Plc
08/13/20244:16AMAlliance NewsAlliance NewsIN BRIEF: Hikma executive Bassam Kanaan sells 45,000 sharesLSE:HIKHikma Pharmaceuticals Plc
08/13/20243:39AMRNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
08/08/20245:33AMAlliance NewsAlliance NewsHikma Pharmaceuticals raises guidance as first-half profit jumps 43%LSE:HIKHikma Pharmaceuticals Plc
08/08/20245:33AMAlliance NewsAlliance NewsHikma Pharmaceuticals raises guidance as first-half profit jumps 43%LSE:HIKHikma Pharmaceuticals Plc
08/08/20241:00AMRNS Regulatory NewsHikma Pharmaceuticals Plc Half-year ReportLSE:HIKHikma Pharmaceuticals Plc
07/29/202410:08AMRNS Regulatory NewsHikma Pharmaceuticals Plc Director DeclarationLSE:HIKHikma Pharmaceuticals Plc
07/15/20241:00AMRNS Regulatory NewsHikma Pharmaceuticals Plc Notice of ResultsLSE:HIKHikma Pharmaceuticals Plc
07/01/20248:47AMRNS Regulatory NewsHikma Pharmaceuticals Plc Total Voting RightsLSE:HIKHikma Pharmaceuticals Plc
06/27/20247:47AMRNS Regulatory NewsHikma Pharmaceuticals Plc Director DeclarationLSE:HIKHikma Pharmaceuticals Plc
06/17/20243:14AMAlliance NewsAlliance NewsHikma adds scale to US injectables business with Xellia acquisitionLSE:HIKHikma Pharmaceuticals Plc
06/17/20243:14AMAlliance NewsAlliance NewsHikma adds scale to US injectables business with Xellia acquisitionLSE:HIKHikma Pharmaceuticals Plc
06/17/20241:00AMRNS Regulatory NewsHikma Pharmaceuticals Plc Hikma acquires Xellia’s assetsLSE:HIKHikma Pharmaceuticals Plc
06/11/20247:05AMAlliance NewsAlliance NewsIN THE KNOW: Citi lifts Hikma price target amid positive industry dataLSE:HIKHikma Pharmaceuticals Plc
 Showing the most relevant articles for your search:LSE:HIK

Your Recent History

USOTC
TGLO
TheGlobe com (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
LEHNQ
Lehman Brothers Financial (CE)
USOTC
AZRH
Azure (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
RNVA
Rennova Health (CE)
USOTC
GVSI
Good Vibrations Shoes (PK)
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
AMRN
Amarin
COIN
XRPUSD
Ripple
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
FDCT
FDCTech (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
MONI
Moon Equity (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads